Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Male Reproductive SystemDRG 707-major-male-pelvic-procedures-with-cc-mcc
    Ask Trek AI about this page

    Major Male Pelvic Procedures with CC/MCC: Inpatient Reimbursement Overview

    DRG 707 includes major male pelvic procedures with a Complication or Comorbidity or Major Complication or Comorbidity and encompasses extensive urologic resections and complex pelvic operations in hospitalized male patients. Proper assignment matters for inpatient reimbursement because the presence of Complication or Comorbidity or Major Complication or Comorbidity increases clinical severity and typically results in higher Medicare payment relative to lower-severity procedure groups.

    Customize your policy alerts

    Sign up for drg 707 policy alerts

    Get alerted when payer policies referencing 707 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 707 Overview

    DRG 707 covers major male pelvic procedures performed on hospitalized adult male patients when a Complication or Comorbidity or Major Complication or Comorbidity is present, typically including extensive urologic resections, reconstructive pelvic surgery, and complex prostate operations. This Diagnosis-Related Group groups cases with higher clinical severity and resource use, which affects inpatient payment under Medicare’s prospective payment system. Cases assigned to this Diagnosis-Related Group generally generate higher reimbursement than lower-severity pelvic procedure groups due to added complications or comorbid conditions. Understanding the clinical scope of DRG 707 is important for accurate coding and payment classification.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative interventions to reduce surgical complications in major male pelvic procedures: randomized or pragmatic trials testing enhanced recovery protocols, antibiotic/antithrombotic timing strategies, or optimized fluid and pain management in men undergoing radical prostatectomy, cystectomy, or pelvic lymphadenectomy. These studies enroll patients scheduled for major male pelvic surgery and measure short-term outcomes such as postoperative infection, bleeding, return of bowel function, length of stay, and 30-day readmission. Results inform clinicians and hospital payers about interventions that safely reduce morbidity and resource use in a high-cost inpatient DRG.
    • Comparative effectiveness studies of surgical technique or extent of resection in male pelvic oncologic operations: prospective cohort or randomized studies comparing approaches (for example radical versus organ-sparing procedures, open versus minimally invasive/robotic approaches, or variations in lymph node dissection templates) in men with prostate, bladder, or pelvic urologic cancers. These trials target heterogeneous surgical candidates stratified by tumor stage, comorbidity, and baseline urinary/sexual function, assessing disease control, functional outcomes, complication rates, and downstream utilization over months to years. Findings help providers and payers balance long-term oncologic benefit and quality-of-life outcomes against upfront inpatient costs captured under this DRG.
    • Post-discharge recovery and health services research focusing on readmission reduction and rehabilitation needs after major male pelvic surgery: observational and interventional studies evaluating care-transition models, home-based rehabilitation, telemonitoring, or targeted outpatient support for men discharged after pelvic procedures. These studies follow patients with varying frailty and comorbidity profiles to identify predictors of readmission, prolonged dependency, or durable functional impairment and to test interventions that reduce post-discharge complications and emergency utilization. Evidence from this research informs discharge planning, case management strategies, and payer policies to reduce costly readmissions and improve value for patients assigned to this DRG.

    Related Codes

    708-MAJOR-MALE-PELVIC-PROCEDURES-WITHOUT-CC-MCC

    Major Male Pelvic Procedures without CC/MCC: Inpatient Reimbursement Overview

    709-PENIS-PROCEDURES-WITH-CC-MCC

    Penis Procedures with CC/MCC: Inpatient Reimbursement Overview

    710-PENIS-PROCEDURES-WITHOUT-CC-MCC

    Penis Procedures without CC/MCC: Inpatient Reimbursement Overview

    711-TESTES-PROCEDURES-WITH-CC-MCC

    Testes Procedures with CC/MCC: Inpatient Reimbursement Overview

    712-TESTES-PROCEDURES-WITHOUT-CC-MCC

    Testes Procedures without CC/MCC: Inpatient Reimbursement Overview

    713-TRANSURETHRAL-PROSTATECTOMY-WITH-CC-MCC

    Transurethral Prostatectomy with CC/MCC: Inpatient Reimbursement Overview

    714-TRANSURETHRAL-PROSTATECTOMY-WITHOUT-CC-MCC

    Transurethral Prostatectomy without CC/MCC: Inpatient Reimbursement Overview

    715-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-FOR-MALIGNANCY-WITH-CC-MCC

    Other Male Reproductive System O.R. Procedures for Malignancy with CC/MCC: Inpatient Reimbursement Overview

    716-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-FOR-MALIGNANCY-WITHOUT-CC-MCC

    Other Male Reproductive System O.R. Procedures for Malignancy without CC/MCC: Inpatient Reimbursement Overview

    717-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-EXCEPT-MALIGNANCY-WITH-CC-MCC

    Other Male Reproductive System O.R. Procedures Except Malignancy with CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 20

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.